Health-Related Quality of Life of Patients Treated with Biological Agents and New Small-Molecule Drugs for Moderate to Severe Crohn’s Disease: A Systematic Review

Crohn’s disease (CD) leads to a poor health-related quality of life (HRQoL). This review aimed to investigate the effect of biological agents and small-molecule drugs in improving the HRQoL of patients with moderate to severe CD. We adopted a systematic protocol to search PubMed and Cochrane Central...

Descripción completa

Detalles Bibliográficos
Autores principales: Aladraj, Hasan, Abdulla, Mohamed, Guraya, Salman Yousuf, Guraya, Shaista Salman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267515/
https://www.ncbi.nlm.nih.gov/pubmed/35807044
http://dx.doi.org/10.3390/jcm11133743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267515/
https://www.ncbi.nlm.nih.gov/pubmed/35807044
http://dx.doi.org/10.3390/jcm11133743

Ejemplares similares